Tredje AP fonden Cuts Stake in Intuitive Surgical, Inc. $ISRG

Tredje AP fonden reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 77,911 shares of the medical equipment provider’s stock after selling 21,311 shares during the period. Tredje AP fonden’s holdings in Intuitive Surgical were worth $34,844,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Rossmore Private Capital boosted its stake in shares of Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after purchasing an additional 20 shares in the last quarter. Activest Wealth Management lifted its stake in Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the last quarter. Vertex Planning Partners LLC boosted its position in Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after buying an additional 21 shares during the period. Accredited Investors Inc. boosted its position in Intuitive Surgical by 2.0% during the third quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock valued at $474,000 after buying an additional 21 shares during the period. Finally, SPC Financial Inc. grew its stake in shares of Intuitive Surgical by 1.3% during the third quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock valued at $722,000 after buying an additional 21 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, Director Gary S. Guthart sold 24,500 shares of the stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the completion of the transaction, the director owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 56,189 shares of company stock worth $30,785,441 over the last quarter. Insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ISRG shares. Wells Fargo & Company boosted their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. HSBC lifted their price target on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday, January 26th. Citigroup reissued a “neutral” rating and set a $590.00 price objective (down previously from $635.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, Robert W. Baird decreased their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $617.23.

Intuitive Surgical Trading Up 0.9%

Shares of NASDAQ ISRG opened at $504.05 on Friday. The firm has a fifty day simple moving average of $535.88 and a two-hundred day simple moving average of $510.51. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $607.35. The firm has a market capitalization of $179.00 billion, a PE ratio of 63.88, a price-to-earnings-growth ratio of 3.87 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.